TrialEuropean heart journal2022

Effect of empagliflozin on circulating proteomics in heart failure: mechanistic insights into the EMPEROR programme.

Faiez Zannad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.